Simvastatin antagonizes tumor necrosis factor-α inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway
Misuzu Yamashita(Kurashiki Central Hospital), Hirofumi Makino(Okayama University Hospital)
Cited by 118
Related Papers
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|609
Innate immunity in diabetes and diabetic nephropathy
|Nature Reviews Nephrology|2015|424
The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis
|Arthritis Research & Therapy|2006|321